These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7567779)

  • 1. Characterization of a P2Y purinoceptor in the brain.
    Simon J; Webb TE; Barnard EA
    Pharmacol Toxicol; 1995 May; 76(5):302-7. PubMed ID: 7567779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
    Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
    Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
    Schäfer R; Reiser G
    Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [35S]adenosine 5'-O-(2-thiodiphosphate) to endothelial cells in culture.
    Wilkinson GF; Boarder MR
    Biochem Pharmacol; 1995 May; 49(10):1411-8. PubMed ID: 7763284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of a recombinant P2Y purinoceptor.
    Simon J; Webb TE; King BF; Burnstock G; Barnard EA
    Eur J Pharmacol; 1995 Nov; 291(3):281-9. PubMed ID: 8719412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.
    Michel AD; Humphrey PP
    Br J Pharmacol; 1996 Jan; 117(1):63-70. PubMed ID: 8825344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat.
    Michel AD; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):608-17. PubMed ID: 8133903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
    Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
    Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 6H1 as a P2Y purinoceptor: P2Y5.
    Webb TE; Kaplan MG; Barnard EA
    Biochem Biophys Res Commun; 1996 Feb; 219(1):105-10. PubMed ID: 8619790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic labelling of P2 purinoceptors in the guinea-pig cochlea.
    Mockett BG; Bo X; Housley GD; Thorne PR; Burnstock G
    Hear Res; 1995 Apr; 84(1-2):177-93. PubMed ID: 7642450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
    von Kügelgen I; Späth L; Starke K
    Br J Pharmacol; 1994 Nov; 113(3):815-22. PubMed ID: 7858872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of [35S]dATPalphaS interaction with P2Y1 purinoceptor in rat brain membranes.
    Oras A; Järv J
    Neurosci Lett; 2004 Jan; 355(1-2):9-12. PubMed ID: 14729222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding characteristics of a human bladder recombinant P2X purinoceptor, labelled with [3H]-alpha beta meATP, [35S]-ATP gamma S or [33P]-ATP.
    Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
    Br J Pharmacol; 1996 Mar; 117(6):1254-60. PubMed ID: 8882623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
    Pintor J; Díaz-Rey MA; Miras-Portugal MT
    Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of [35S]dATP alpha S binding sites in the adult rat neuraxis.
    Simon J; Webb TE; Barnard EA
    Neuropharmacology; 1997 Sep; 36(9):1243-51. PubMed ID: 9364479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.
    King BF; Dacquet C; Ziganshin AU; Weetman DF; Burnstock G; Vanhoutte PM; Spedding M
    Br J Pharmacol; 1996 Mar; 117(6):1111-8. PubMed ID: 8882604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
    Schachter JB; Harden TK
    Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of [35S]dATP alpha S interaction with P2y(1) nucleotide receptor.
    Oras A; Kilk K; Kunapuli S; Barnard EA; Järv J
    Neurochem Int; 2002 Apr; 40(5):381-6. PubMed ID: 11821144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
    Ho C; Hicks J; Salter MW
    Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney.
    Eltze M; Ullrich B
    Eur J Pharmacol; 1996 Jun; 306(1-3):139-52. PubMed ID: 8813626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.